返回
Sunshine Lake Pharma Co., Ltd.（06887.HK）價格
06887.HK 股價走勢圖
SUNSHINE PHARMA (06887.HK)
Sunshine Lake Pharma Co., Ltd.
HK$43.38
0%
$0
休市： Feb 16, 12:00:00 HKT
暫無資料Earnings FAQ
06887.HK 最近的每股盈餘與預期相比如何？
Sunshine Lake Pharma Co., Ltd. 06887.HK 上一季度的收入表現如何？
Sunshine Lake Pharma Co., Ltd. 的收入預期是多少？
Sunshine Lake Pharma Co., Ltd. 的盈利品質評分是多少？
Sunshine Lake Pharma Co., Ltd. 何時發布財報？
Sunshine Lake Pharma Co., Ltd. 的預期收益是多少？
Sunshine Lake Pharma Co., Ltd. 是否超出收益預期？
關鍵數據
前收市價
$43.38
開盤價
$43.38
當日範圍
$42.9 - $43.62
52週區間
$40.54 - $62.3
交易量
14.5K
平均成交量
394.4K
每股盈餘 (TTM)
-0.35
股息收益率
--
市值
$4.8B
什麼是 SUNSHINE PHARMA？
Sunshine Lake Pharma Co., Ltd. operates as a pharmaceutical company. The company is headquartered in Dongguan, Guangdong and currently employs 6,533 full-time employees. The company went IPO on 2025-08-07. The firm focuses on innovative drugs and is also involved in modified new drugs, generic drugs and biosimilars. The Company’s anti-infective products include Kewei (oseltamivir phosphate), for the treatment of influenza (in particular, Type A and Type B influenza viruses), Dongweien (emitasvir phosphate), for the treatment of hepatitis C, and generic drugs for the treatment of infections caused by sensitive bacteria, namely Clarithromycin, Levofloxacin and Moxifloxacin Hydrochloride. The Company’s commercialized chronic disease treatment drugs primarily focus on the treatment of diabetes, hyperuricemia, hypertension and stomach acid related disease, including insulin products and generic drugs. The firm also focuses on therapeutic area of oncology.